1. Prognostic value of plasma IL-27 on biological viability of hepatic cystic echinococcosis
- Author
-
Shadike Apaer, Hai-zhang Ma, Tao Li, Gang Yao, Qi Zeng, Jing Wu, Nuerzatijiang Anweier, Xiapukaiti Fulati, Jin-ming Zhao, Hao Wen, and Tuerhongjiang Tuxun
- Subjects
Echinococcosis ,Biological viability ,IL-27 ,Biomarker ,Infectious and parasitic diseases ,RC109-216 - Abstract
Objectives: To investigate potential biomarkers for distinguishing biological viability of hepatic cystic echinococcosis. Methods: Using Luminex assay we measured plasma concentrations of cytokine and chemokine in patients with active and non-active cysts (hepatic cystic echinococcosis (HCE), n = 47) and stable/progressive hepatic alveolar echinococcosis (HAE, n = 38), and in comparable infection-free volunteers (n = 48). Disease progression was staged according to the classification standard. Results: Compared with healthy controls, enhanced elevation was found of T helper 22 type cytokine interleukin (IL)-22 and chemokines Eotaxin, interferon-γ inducible protein-10, monocyte chemoattractant protein-1, and stromal cell-derived factor-1α concentrations in HAE patients, and IL-22, growth-related oncogene α, monocyte chemoattractant protein-1, regulated on activation normal T-expressed and secreted, and stromal cell-derived factor-1α concentrations in HCE patients (P < 0.05–0.001). For HCE patients, only IL-27 concentrations in non-active HCE were significantly lower than in active HCE. In logistic regression analysis, IL-27
- Published
- 2021
- Full Text
- View/download PDF